The current situation is that the output value of ethnic medical devices is less than one-third of the output value of the pharmaceutical industry, and far lower than the level of 1:1 in developed countries.
On September 12th, DeviceChina2015 China Medical Device Summit Forum was held in Suzhou as scheduled. Jiang Feng, executive vice president of China Medical Device Industry Association, gave a keynote speech on “Thoughts to Enhance the National Medical Device Industryâ€.
When talking about national medical devices, there are some regrets in the industry that "hate iron is not steel". Although the national policy is increasingly inclined to localization of high-end medical devices, as consumers, it is hoped that the market will provide "the most Good treatment technology, the cheapest price for the people."
The pharmaceutical industry and medical devices, the former is a medical and health industry based on "chemistry and biology"; the latter is a human instrument engineering project centered on "mechanics and electromagnetism in physics".
As an indispensable part of national health care, what is the global output value of the pharmaceutical industry and the medical device industry? What is the domestic and international investment in research and development in the field of pharmaceuticals? Can the medical device model replicate the drug model?
Under the global economic tide, should we redefine "localization"? How should domestic enterprises and international enterprises get along with each other to better realize the internationalization of domestic enterprises and the localization of international enterprises, and to maximize the health of the people while achieving win-win cooperation?
In view of a series of confusions in the above-mentioned industries, President Jiang showed the data of the sample enterprises above the scale of the Ministry of Industry and Information Technology at the end of 2014. The main business income of the medical equipment and equipment manufacturing and sanitary materials and medical products manufacturing industries totaled 379.839 billion yuan; The China Medical Device Industry Association estimates that the output value of medical equipment will exceed 500 billion yuan.
According to CFDA statistics, as of the end of 2014, there were 16,169 Chinese medical device manufacturers; 3,966 in one category, 9,355 in the second category, and 2,848 in the third category; medical device management (secondary and tertiary) with license management Enterprise 189,833.
The output value of medical devices in China is less than one-third of the output value of the pharmaceutical industry, far lower than the level of 1:1 in developed countries. In the report of the speech, President Jiang showed that the global medical device output accounted for 42% of the total output value of the pharmaceutical industry, including developed countries. The ratio of output value of medical equipment to pharmaceutical industry is 1:1; in contrast, the ratio of output value of medical equipment and pharmaceutical industry in China is only 1:3~4, which is far lower than that of developed countries; and China's medical equipment products account for about the global market. The share of local enterprises is only 30% of the domestic market, and the domestic medical equipment market still presents a monopoly of foreign products.
Four major reasons for the backward development of domestic and foreign equipment and the backwardness of the medical device industry, Jiang said that the lack of product innovation, serious lack of research and development investment, lack of innovation system and supporting policies are the main reasons for the gap between China's medical device industry and developed countries.
It is worth mentioning that China has a huge gap in the construction of sustainable technological innovation capabilities with industrial strategic heights, which is embodied in “low innovation capability, high-end and low-end products, imitation and improvement of products, and almost no original productsâ€; The overall pharmaceutical industry R & D investment accounted for 1-2% (medical devices for 3%), while the developed countries average 15-18% (medical devices for more than 15%); innovation capacity building in China can not be SMEs The main industry is completed by itself. In contrast, the world's medical industry powers have implemented a large amount of government intervention in innovation (in developed countries, small enterprises make originals, large enterprises do improvement and industrialization); Chinese enterprises from innovation to The whole process of industrialization has a low success rate, and the conversion rate of research and development achievements of scientific research institutes is less than 10%. The concept of translational medicine is a conceptual stage, and there is a lack of innovative intermediary services. It is difficult for social capital and industry to connect efficiently; the government's support policy for innovative products Not enough, mainly reflected in R&D expenditure management and taxation issues, patent protection, registration green channel, pricing and bidding procurement .
The core of upgrading the national medical device industry is to create innovative capacity for sustainable development. Innovation is the first factor; the drug model cannot replace the device model; technological innovation is more important than scale indicators, and medical expenses must be reduced through innovative new technologies.
Secondly, China's enterprises must have an international perspective, that is, the industry needs to pay attention to the high-end manufacturing leader; the policy departments and departments are comprehensively coordinated, clearly divided, and do top-level design of policies, layout, industry chain, talents and products.
Third, we must attach importance to strengthening intellectual property protection. Intellectual property protection helps to establish a dominant position in the international industry, contribute to the building of national brands and industrial groups, guide enterprises and talents to gather together, and achieve Chinese creation.
Finally, it is necessary to vigorously create an environment and atmosphere that supports innovation, namely, providing research funding support and venture capital docking; implementing tax incentives for corporate R&D personnel to facilitate listing, property rights transactions and mortgage evaluation; regulatory, registration and procurement policies are skewed.
Under the global economic tide, should we re-examine "localization"?
Deng Xiaoping once said that regardless of white cats and black cats, it is a good cat to catch rats. Nowadays, for the development of medical device industry and technology, we should look at it from an objective perspective. While protecting the development of national exhibition industry, we should realize that it is the key to provide users/patients with the best quality and low price products. Respect the choice of doctors and patients.
JRT has been R&D Laser Distance Sensor every year. In this part, we put every new sensor here. To help our customer to find the lastest item. To know the updates we are doing, what's new for laser distance modules. What kind of Laser Distance Meter sensor we can make.
Best Regards
JRT Team
New Laser Distance Sensor,New Laser Distance Module,New Distance Sensor,New Laser Sensor
Chengdu JRT Meter Technology Co., Ltd , https://www.infrareddistancesensor.com